XBONZY
Dr. Reddy’s Laboratories shares jump over 1% as European Commission approves biosimilar AVT03Dr. Reddy's Laboratories secured European Commission approval for AVT03, a biosimilar to Prolia and Xgeva, for osteoporosis and bone compli...
Dr Reddy’s gets EC nod for AVT03: New Prolia and Xgeva biosimilar set to launch across EuropeDr. Reddy's Laboratories has secured European Commission marketing approval for AVT03, a biosimilar to Prolia and Xgeva, used for bone-rela...
- Load More